<DOC>
	<DOCNO>NCT01006291</DOCNO>
	<brief_summary>This trial conduct Africa , Asia , Europe South America . The aim clinical trial compare NN1250 ( insulin degludec ( IDeg ) insulin glargine ( IGlar ) patient type 2 diabetes . Subjects treat oral antidiabetic drug ( ) ( OAD ( ) ) continue current OAD treatment stable , prerandomisation dose level dose frequency .</brief_summary>
	<brief_title>Comparison NN1250 With Insulin Glargine Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 2 diabetes mellitus ( diagnose clinically ) least 6 month Current treatment : oral antidiabetic drug ( ) ( OAD ( ) ) alone , basal insulin alone combination OAD ( ) basal insulin . Allowed OADs : Metformin , insulin secretagogues ( sulphonylureas ( SU ) glinides ) , pioglitazone unchanged dose least 3 month prior Visit 1 HbA1c : OADs user 7.011.0 % ( inclusive ) , basal insulin with/without OADs user 7.010.0 % ( inclusive ) central laboratory analysis Body Mass Index ( BMI ) equal 40.0 kg/m^2 Cancer medical history cancer hereof Use within last 3 month prior Visit 1 : glucagonlike peptide1 ( GLP1 ) receptor agonist ( exenatide , liraglutide ) , rosiglitazone , dipeptidyl peptidase IV ( DPPIV ) inhibitor , alphaglucosidaseinhibitors Cardiovascular disease , within last 6 month prior Visit 1 , define : stroke ; decompensated heart failure New York Heart Association ( NYHA ) class III IV ; myocardial infarction ; unstable angina pectoris ; coronary arterial bypass graft angioplasty Uncontrolled treated/untreated severe hypertension ( systolic blood pressure least 180 millimetre ( mm ) mercury ( Hg ) and/or diastolic blood pressure least 100 mmHg ) Pregnancy , breastfeeding , intention become pregnant use adequate contraceptive measure accord local requirement Cancer medical history cancer hereof ( except basal cell skin cancer squamous cell skin cancer )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>